Huons Global Co Ltd
KOSDAQ:084110
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
H
|
Huons Global Co Ltd
KOSDAQ:084110
|
611.4B KRW |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
995.7B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
573.2B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
281.7B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
300.5B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
231.3B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.3B GBP |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.7B USD |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
Huons Global Co Ltd
Glance View
Huons Global Co., Ltd. engages in the management of its subsidiaries and provision of botulinum toxin. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2006-12-19. Along with its subsidiaries, the Company operates its business through two segments: pharmaceutical segment and glass container segment. The pharmaceutical segment produces pharmaceutical products including parenteral injections such as lidocaines, merit C injections; tablets such as phentermines, diet pills and others; capsules such as Daisen and Fuxetine and other ethical and over-the-counter drugs. The glass container segment produces ampoules, vials, cartridges and caps for used of medicals, foods and cosmetics. The firm also manufactures medical devices such as kits, derma injectors and other injector.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Huons Global Co Ltd is 49.9%, which is below its 3-year median of 53.1%.
Over the last 3 years, Huons Global Co Ltd’s Gross Margin has decreased from 54% to 49.9%. During this period, it reached a low of 49.9% on Oct 30, 2025 and a high of 55.6% on Sep 30, 2023.
